![Manuel Castellón Leal](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Manuel Castellón Leal
Private Equity Investor at Cross Road Biotech Inversiones Biotecnológicas SGEIC SA
Profile
Mr. Manuel Castellón Leal is a Founding Partner & Legal Advisor at Cross Road Biotech Inversiones Biotecnológicas SGEIC SA. Mr. Castellón Leal also served on the board at Traslational Cancer Drugs Pharma SL.
He received his undergraduate degree from Universidad Complutense de Madrid and a graduate degree from the Instituto de Empresa SL.
Manuel Castellón Leal active positions
Companies | Position | Start |
---|---|---|
Cross Road Biotech Inversiones Biotecnológicas SGEIC SA
![]() Cross Road Biotech Inversiones Biotecnológicas SGEIC SA Investment ManagersFinance Cross Road Biotech Inversiones Biotecnologicas SGEIC SA (Cross Road Biotech Inversiones Biotecnologicas) is a venture capital firm founded in 2001 by Enrique Castellon Leal. The firm is headquartered in Madrid, Spain. | Private Equity Investor | 2000-12-31 |
Former positions of Manuel Castellón Leal
Companies | Position | End |
---|---|---|
Traslational Cancer Drugs Pharma SL
![]() Traslational Cancer Drugs Pharma SL BiotechnologyHealth Technology Traslational Cancer Drugs Pharma SL engages in the discovery and development of therapeutic solutions for the treatment of cancer. Its TCD-717 choline kinase alpha inhibitor is an intravenously-administered small molecule designed to target cancer cells. It also provides technology in-licensing and out-licensing services. The company was founded by Juan Carlos San Juan on July 29, 2005 and is headquartered in Valladolid, Spain. | Director/Board Member | - |
Training of Manuel Castellón Leal
Universidad Complutense de Madrid | Undergraduate Degree |
Instituto de Empresa SL | Graduate Degree |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 2 |
---|---|
Cross Road Biotech Inversiones Biotecnológicas SGEIC SA
![]() Cross Road Biotech Inversiones Biotecnológicas SGEIC SA Investment ManagersFinance Cross Road Biotech Inversiones Biotecnologicas SGEIC SA (Cross Road Biotech Inversiones Biotecnologicas) is a venture capital firm founded in 2001 by Enrique Castellon Leal. The firm is headquartered in Madrid, Spain. | Finance |
Traslational Cancer Drugs Pharma SL
![]() Traslational Cancer Drugs Pharma SL BiotechnologyHealth Technology Traslational Cancer Drugs Pharma SL engages in the discovery and development of therapeutic solutions for the treatment of cancer. Its TCD-717 choline kinase alpha inhibitor is an intravenously-administered small molecule designed to target cancer cells. It also provides technology in-licensing and out-licensing services. The company was founded by Juan Carlos San Juan on July 29, 2005 and is headquartered in Valladolid, Spain. | Health Technology |
- Stock Market
- Insiders
- Manuel Castellón Leal